Tag: Survival
Survival Up for CABG With Surgical Ablation in Atrial Fibrillation
Medicare beneficiaries undergoing concomitant surgical ablation have risk-adjusted median survival advantage
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab
Nodal Irradiation Does Not Reduce Recurrence, Death for ypN0 Breast Cancer
No reduction seen in risk with adjuvant regional nodal irradiation among patients with node-positive breast cancer who reached ypN0 status after neoadjuvant chemo
ASCO: Disease-Free Survival Prolonged With Exercise Program in Colon Cancer
Improved survival seen with structured program in patients with resected colon cancer who have completed adjuvant chemo
ASCO: Vepdegestrant Ups Survival in ER+, HER2− Advanced Breast Cancer With ESR1 Mutations
Progression-free survival longer with vepdegestrant than fulvestrant in subgroup with ESR1 mutations, but not in the overall population
Culturally Tailored Intervention Beneficial for Latina Breast Cancer Survivors
Clinically relevant but not statistically significant improvement seen in anxiety and fatigue versus usual services
18.6 Million Cancer Survivors in the United States as of Jan. 1, 2025
Racial differences in treatment common, including lower likelihood of surgery for stage I to II lung cancer in Black patients
Physical Activity Linked to Better Survival for Specific Cancer Types
Engaging in leisure-time MVPA linked to improved survival for various cancer types including bladder, breast, colon
Low Alcohol Use Disorder Treatment Rates Seen in Cancer Survivors
One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent
Worse Mental Health Trajectories Seen for Survivors of Teen, Young Adult Cancer
Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors
